Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI)
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Mingot-Castellano, M. Eva
- dc.contributor.author Sánchez González, Blanca
- dc.contributor.author Spanish Immune Thrombocytopenia Group (GEPTI)
- dc.date.accessioned 2024-10-24T06:55:18Z
- dc.date.available 2024-10-24T06:55:18Z
- dc.date.issued 2023
- dc.description.abstract Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.
- dc.format.mimetype application/pdf
- dc.identifier.citation Mingot-Castellano ME, Canaro Hirnyk M, Sánchez-González B, Álvarez-Román MT, Bárez-García A, Bernardo-Gutiérrez Á, et al. Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI). J Clin Med. 2023 Oct 10;12(20):6422. DOI: 10.3390/jcm12206422
- dc.identifier.doi http://dx.doi.org/10.3390/jcm12206422
- dc.identifier.issn 2077-0383
- dc.identifier.uri http://hdl.handle.net/10230/68331
- dc.language.iso eng
- dc.publisher MDPI
- dc.relation.ispartof J Clin Med. 2023 Oct 10;12(20):6422
- dc.rights © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Fostamatinib
- dc.subject.keyword Glucocorticoids
- dc.subject.keyword Intravenous immunoglobulins
- dc.subject.keyword Primary immune thrombocytopenia
- dc.subject.keyword Recommendations
- dc.subject.keyword Rituximab
- dc.title Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI)
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion